RdRP-IN-7, a RNA-dependent RNA polymerase (RdRp) inhibitor, demonstrates efficacy against SARS-CoV-2 infection with an inhibitory concentration (IC50) of 8.2 µM and (IC90) of 14.1 µM, alongside a cytotoxic concentration (CC90) of 79.1 µM, rendering it suitable for antiviral research.
Molecular Weight:
559.85
Formula:
C26H45N7O3Si2
Target:
SARS-CoV
* VAT and and shipping costs not included. Errors and price changes excepted
